{"context":{"query":">>mesh>>pharmgkb_clinical","source_dataset":"mesh","target_dataset":"pharmgkb_clinical"},"stats":{"queried":1,"total":9,"mapped":1},"pagination":{"has_next":false},"schema":"id|variant|gene|type|level_of_evidence|chemicals|phenotypes","mappings":[{"input":"D001749","source":"D001749|Urinary Bladder Neoplasms","targets":["RS10964552_MLLT3_1|rs10964552|MLLT3|Efficacy|3|cisplatin|Urinary Bladder Neoplasms","RS1128503_ABCB1_20|rs1128503|ABCB1|Metabolism/PK|3|sirolimus;temsirolimus|Urinary Bladder Neoplasms","RS2032582_ABCB1_27|rs2032582|ABCB1|Metabolism/PK|3|sirolimus;temsirolimus|Hematopoietic stem cell transplantation;Kidney Transplantation;Urinary Bladder Neoplasms","RS2228001_TMEM43_XPC_1|rs2228001|TMEM43,XPC|Toxicity|3|cisplatin|Neutropenia;Urinary Bladder Neoplasms","RS2228001_TMEM43_XPC_2|rs2228001|TMEM43,XPC|Toxicity|3|cisplatin|Drug Toxicity;Urinary Bladder Neoplasms","RS244898_RARS1_1|rs244898|RARS1|Efficacy|3|cisplatin|Urinary Bladder Neoplasms","RS3814055_NR1I2_3|rs3814055|NR1I2|Toxicity,Metabolism/PK|3|sirolimus;temsirolimus|adverse events;Gastrointestinal toxicity;Myelosuppression;Urinary Bladder Neoplasms","RS6785049_NR1I2_2|rs6785049|NR1I2|Toxicity,Metabolism/PK|3|sirolimus;temsirolimus|Gastrointestinal toxicity;Myelosuppression;Urinary Bladder Neoplasms","RS7937567_CSNK2A3_GALNT18_1|rs7937567|CSNK2A3,GALNT18|Efficacy|3|cisplatin|Urinary Bladder Neoplasms"]}]}